All In Biotech

Free tool

FAERS Monitor: Revatio

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 203109 or its brand name (Revatio, Sildenafil Citrate). Reports on generic versions are filed under their own applications.

Reports

55,254

Serious

38,247

69% of reports

Hospitalization

23,887

Death reported

10,436

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea8,445
  • headache5,765
  • death5,676
  • diarrhoea4,437
  • nausea3,833
  • fatigue3,640
  • dizziness3,413
  • cough3,389
  • pneumonia3,057
  • malaise2,716
  • fluid retention2,314
  • hypotension2,215
  • vomiting2,113
  • off label use2,014
  • drug ineffective1,937

Reports by year received

View as table
YearReports
200460
2005120
2006309
2007259
2008493
2009696
20101,588
20112,325
20122,533
20132,825
20145,734
20154,431
20163,367
20174,035
20183,584
20193,653
20203,427
20212,839
20222,721
20232,774
20242,725
20252,704
20262,052

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,998,905 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
fluid retentionSignal2,31418.117.435,746
dyspnoeaSignal8,4455.75.633,537
coughSignal3,3894.64.59,700
hypotensionSignal2,2154.24.15,471
pneumoniaSignal3,0573.63.55,826
headacheSignal5,7653.53.410,638
diarrhoeaSignal4,4372.62.64,582
dizzinessSignal3,4132.62.53,464
deathSignal5,6762.52.55,378
malaiseSignal2,7162.42.32,172
nausea3,8331.81.81,540
fatigue3,6401.81.71,294
vomiting2,1131.71.6639
off label use2,0140.90.837
drug ineffective1,9370.60.5718

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.